EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The p53/miRNA Axis in Breast Cancer

Reza Shah Hosseini, Seyed Mohammad Nouri, Pooja Bansal, Ahmed Hjazi, Harpreet Kaur, Anaheed Hussein Kareem, Abhinav Kumar, Rafil Adnan Hussein Al Zuhairi, Nadhim Allawi Al-Shaheri, Parya Mahdavi iD

DNA and Cell Biology · 2024

DOI: 10.1089/dna.2024.0181 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift DNA and Cell Biology, 2024. Verfasst von Reza Shah Hosseini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Istanbul Medipol University, Faculty of Medicine, Istanbul, Turkey. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms, Tumor Suppressor Protein p53, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 119 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the main health issues in the modern world is cancer, with breast cancer (BC) as one of the most common types of malignancies. Different environmental and genetic risk factors are involved in the development of BC. One of the primary genes implicated in cancer development is the p53 gene, which is also known as the "gatekeeper" gene. p53 is involved in cancer development by interacting with numerous pathways and signaling factors, including microRNAs (miRNAs). miRNAs are small noncoding RNA molecules that regulate gene expression by binding to the 3' untranslated region of target mRNAs, resulting in their translational inhibition or degradation. If the p53 gene is mutated or degraded, it can contribute to the risk of BC by disrupting the expression of miRNAs. Similarly, the disruption of miRNAs causes the negative regulation of p53. Therefore, the p53/miRNA axis is a crucial pathway in the progression or prevention of BC, and understanding the regulation and function of this pathway may contribute to the development of new therapeutic strategies to help treat BC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsBreast NeoplasmsTumor Suppressor Protein p53Gene Expression Regulation, NeoplasticHumansFemaleSignal Transduction

Stichwörter der Autor:innen

breast cancermiRNAp53signaling pathway

Substanzen

MicroRNAsTumor Suppressor Protein p53TP53 protein, human

Autor:innen und Institutionen

  • Istanbul Medipol University, Faculty of Medicine, Istanbul, Turkey.
  • Zanjan University of medical science, Zanjan, Iran.
  • Department of Biotechnology and Genetics, Jain (Deemed-to-be) University, Bengaluru, Karnataka, India.
  • Department of Allied Healthcare and Sciences, Vivekananda Global University, Jaipur, Rajasthan, India.
  • Department of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
  • School of Basic & Applied Sciences, Shobhit University, Gangoh, Uttar Pradesh, India.

ORCID-Profile: Parya Mahdavi

Zitieren

APA

Shah Hosseini, R., Nouri, S. M., Bansal, P., Hjazi, A., Kaur, H., Hussein Kareem, A., Kumar, A., Al Zuhairi, R. A. H., Al-Shaheri, N. A., & Mahdavi, P. (2024). The p53/miRNA Axis in Breast Cancer. DNA and Cell Biology. https://doi.org/10.1089/dna.2024.0181

Vancouver

Shah Hosseini R, Nouri SM, Bansal P, Hjazi A, Kaur H, Hussein Kareem A, et al. The p53/miRNA Axis in Breast Cancer. DNA and Cell Biology. 2024. doi:10.1089/dna.2024.0181

BibTeX
@article{ShahHosseini2024,
  author = {Shah Hosseini, Reza and Nouri, Seyed Mohammad and Bansal, Pooja and Hjazi, Ahmed and Kaur, Harpreet and Hussein Kareem, Anaheed and Kumar, Abhinav and Al Zuhairi, Rafil Adnan Hussein and Al-Shaheri, Nadhim Allawi and Mahdavi, Parya},
  title = {The p53/miRNA Axis in Breast Cancer},
  journal = {DNA and Cell Biology},
  year = {2024},
  doi = {10.1089/dna.2024.0181}
}
Kostenlos starten →